What is the latest status of the project “GSK Biologics Flex Factory Construction”?

The status recorded for “GSK Biologics Flex Factory Construction” is planned.

What is the budget and commercial profile for the project “GSK Biologics Flex Factory Construction”?

Taiyo normalizes the budget of “GSK Biologics Flex Factory Construction” to USD 1200000000.

Where can I verify the source and access all details for “GSK Biologics Flex Factory Construction”?

This Taiyo project page references Business Facilities along with the original URL (https://businessfacilities.com/gsk-to-invest-30b-in-u-s-over-next-5-years). Taiyo standardizes official data into a consistent, searchable project profile.

GSK Biologics Flex Factory Construction

Sector: Manufacturing (Industrial) • Location: Pennsylvania, United States

Source: Business Facilities

Project

Planned

GSK plans to invest $1.2 billion in advanced manufacturing facilities including the construction of a new biologics flex factory at Upper Merion, Pennsylvania. The factory aims to deliver new medicines for respiratory diseases and cancer, incorporating AI and advanced digital technologies. Construction is planned to commence in 2026.

Status: Prospective
Sector: Manufacturing (Industrial)
Location: Pennsylvania, United States of America
Updated: 22 Jul 2026
Source: Business Facilities

ConstructChat

Ask ConstructChat about GSK Biologics Flex Factory Construction

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “GSK Biologics Flex Factory Construction” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Pennsylvania, United States. Taiyo aggregates data on it from Business Facilities.

Participants

Not available for this record.

Status

Original status	planned
Taiyo status	Prospective
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	GSK plans to invest $1.2 billion in advanced manufacturing facilities including the construction of a new biologics flex factory at Upper Merion, Pennsylvania. The factory aims to deliver new medicines for respiratory diseases and cancer, incorporating AI and advanced digital technologies. Construction is planned to commence in 2026.
Original sector	Life Sciences
Budget

Location

Country	United States of America (USA)
State	Pennsylvania

Source

Source	Business Facilities
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial)
Article published date	2025-09-21

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

GSK Biologics Flex Factory Construction

Ask ConstructChat about GSK Biologics Flex Factory Construction

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States